[Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer]

Gan To Kagaku Ryoho. 2002 Dec;29(13):2537-9.
[Article in Japanese]

Abstract

Hypercalcemia of malignancy is a common problem for cancer clinicians. Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer is reported herein. The patient was a 36-year-old man who had neck lymph node metastases due to recurrence of squamous cell carcinoma of the buccal mucosa and complained of cloudiness of consciousness due to hypercalcemia. The patient was administered pamidronate. A fine reduction in serum calcium was observed and cloudiness of consciousness was also alleviated. Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / secondary
  • Consciousness Disorders / etiology
  • Diphosphonates / therapeutic use*
  • Drug Administration Schedule
  • Humans
  • Hypercalcemia / drug therapy*
  • Hypercalcemia / etiology
  • Lymphatic Metastasis
  • Male
  • Mouth Neoplasms / drug therapy*
  • Mouth Neoplasms / pathology
  • Mouth Neoplasms / psychology
  • Pamidronate
  • Quality of Life

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Pamidronate